Real Brokerage (REAX) Form 144: Option Exercise and Planned Sale on NASDAQ
Rhea-AI Filing Summary
Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 7,591 common shares with an aggregate market value of $34,159.50, to be sold on or about 08/15/2025 on NASDAQ. The shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists the total number of outstanding shares as 208,121,000. The notice also includes an extensive list of prior open-market sales over the past three months by Tamir Poleg, consisting of multiple transactions of common stock on dates from 05/16/2025 through 08/13/2025, including several large blocks (tens of thousands of shares) with individual gross proceeds in the hundreds of thousands of dollars.
Positive
- Transparent disclosure of the proposed sale including shares, value, date, and exchange
- Acquisition method disclosed (stock option exercise) and cash payment noted
- Comprehensive past-sales listing provides clear history of recent insider dispositions
Negative
- Frequent large insider sales by the same individual over the past three months are reported
- Potential market impact from aggregated insider sales given multiple sizable transactions (tens of thousands of shares)
Insights
TL;DR: Routine disclosure of an insider option exercise and planned resale; large recent dispositions by the same individual may be noteworthy for liquidity analysis.
The Form 144 documents a customary post-exercise resale notice for 7,591 shares valued at $34,159.50, to be sold on NASDAQ. The shares were acquired via option exercise and paid in cash on the acquisition date, which is explicitly reported. Material context comes from the detailed schedule of prior sales by Tamir Poleg across May to August 2025, which shows numerous sizeable transactions and substantial gross proceeds. From a trading-flow perspective, these reported sales provide clear evidence of insider liquidity events; the filing itself does not contain forward-looking or operational company data.
TL;DR: Disclosure complies with Rule 144 reporting requirements; repeated insider sales are documented but no allegation of undisclosed adverse information is made.
The filer affirms the absence of undisclosed material adverse information as required. The filing shows the seller acquired the securities via stock option exercise and intends an open-market sale. The comprehensive list of past three-month sales by the same individual provides transparent history of dispositions, which is useful for governance and insider-transaction monitoring. The document is procedural and does not indicate any governance action beyond routine insider selling and the accompanying attestation.
FAQ
What is being reported in the REAX Form 144?
How were the shares being sold acquired?
Who has recent sales listed in the filing?
How many shares outstanding does the filing show?
On which exchange will the proposed sale occur?
